Prolaris is a genomic test that measures the expression levels of genes involved in cell cycle progression. It is primarily used to assess the aggressiveness of prostate cancer by evaluating how quickly cancer cells are dividing and growing. This test provides a Prolaris Score, which helps to predict the risk of cancer progression.
